Vanguard Personalized Indexing Management
PTCT icon

Vanguard Personalized Indexing Management’s PTC Therapeutics PTCT Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$607K Buy
7,445
+127
+2% +$9.17K 0.01% 1291
2026
Q1 		$499K Buy
7,318
+3,270
+81% +$232K ﹤0.01% 1316
2025
Q4 		$307K Buy
4,048
+299
+8% +$21.7K ﹤0.01% 1513
2025
Q3 		$230K Buy
+3,749
New +$195K ﹤0.01% 1627

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Vanguard Personalized Indexing Management's PTCT Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its PTC Therapeutics (PTCT) stake by 1.7% in Q2 2026, buying an estimated $9.17K and bringing the position to 7,445 shares worth $607K. The position accounts for 0.01% of the portfolio, ranked #1291.

Vanguard Personalized Indexing Management first reported a position in PTCT in Q3 2025 and has held it in 4 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Vanguard Personalized Indexing Management held 7,445 shares of PTC Therapeutics worth $607K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 127 PTC Therapeutics shares in Q2 2026, an estimated $9.17K.
  • PTC Therapeutics made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1291 holding.
  • Vanguard Personalized Indexing Management first reported a position in PTC Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.